Summit Therapeutics Inc

Summit Therapeutics Inc (SMMT) receives a Peer perform rating from Wolfe Research
Jaxson Clark
In a filing, Summit Therapeutics Inc revealed its Director Xia Yu acquired Company’s shares for reported $10.0 million on Oct ...

SMMT (Summit Therapeutics Inc) may reap gains as insiders became active recently
Roman Campbell
Summit Therapeutics Inc’s filing revealed that its Director Xia Yu acquired Company’s shares for reported $10.0 million on Oct 21 ...

Taking a Closer Look At Summit Therapeutics Inc (SMMT) Following Its Recent Trade
Daniel Torres
Summit Therapeutics Inc’s recent filing unveils that its Director Xia Yu acquired Company’s shares for reported $10.0 million on Oct ...

Summit Therapeutics Inc (SMMT) may enjoy gains as insiders got busy in the recent days
Samantha Gray
Summit Therapeutics Inc’s recent filing unveils that its Director Xia Yu acquired Company’s shares for reported $10.0 million on Oct ...





